NCS MULTISTAGE HOLDINGS INC (NCSM) Fundamental Analysis & Valuation

NASDAQ:NCSMUS6288772014

Current stock price

61.74 USD
-11.26 (-15.42%)
Last:

This NCSM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. NCSM Profitability Analysis

1.1 Basic Checks

  • NCSM had positive earnings in the past year.
  • NCSM had a positive operating cash flow in the past year.
  • In multiple years NCSM reported negative net income over the last 5 years.
  • Of the past 5 years NCSM 4 years had a positive operating cash flow.
NCSM Yearly Net Income VS EBIT VS OCF VS FCFNCSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • NCSM has a Return On Assets of 13.11%. This is amongst the best in the industry. NCSM outperforms 93.33% of its industry peers.
  • NCSM has a better Return On Equity (18.81%) than 88.33% of its industry peers.
  • NCSM has a Return On Invested Capital (5.51%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 13.11%
ROE 18.81%
ROIC 5.51%
ROA(3y)5.12%
ROA(5y)2.25%
ROE(3y)7.35%
ROE(5y)3.15%
ROIC(3y)N/A
ROIC(5y)N/A
NCSM Yearly ROA, ROE, ROICNCSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

  • NCSM's Profit Margin of 12.93% is amongst the best of the industry. NCSM outperforms 90.00% of its industry peers.
  • NCSM's Operating Margin of 5.79% is in line compared to the rest of the industry. NCSM outperforms 43.33% of its industry peers.
  • NCSM's Gross Margin of 41.08% is amongst the best of the industry. NCSM outperforms 83.33% of its industry peers.
  • In the last couple of years the Gross Margin of NCSM has remained more or less at the same level.
Industry RankSector Rank
OM 5.79%
PM (TTM) 12.93%
GM 41.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y-0.07%
NCSM Yearly Profit, Operating, Gross MarginsNCSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

7

2. NCSM Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NCSM is destroying value.
  • Compared to 1 year ago, NCSM has more shares outstanding
  • NCSM has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NCSM has been reduced compared to a year ago.
NCSM Yearly Shares OutstandingNCSM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
NCSM Yearly Total Debt VS Total AssetsNCSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 2.04 indicates that NCSM is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.04, NCSM perfoms like the industry average, outperforming 48.33% of the companies in the same industry.
  • NCSM has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
  • NCSM's Debt to FCF ratio of 0.37 is amongst the best of the industry. NCSM outperforms 90.00% of its industry peers.
  • NCSM has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • NCSM has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. NCSM outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.37
Altman-Z 2.04
ROIC/WACC0.63
WACC8.74%
NCSM Yearly LT Debt VS Equity VS FCFNCSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • NCSM has a Current Ratio of 4.27. This indicates that NCSM is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.27, NCSM belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
  • A Quick Ratio of 2.91 indicates that NCSM has no problem at all paying its short term obligations.
  • The Quick ratio of NCSM (2.91) is better than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 4.27
Quick Ratio 2.91
NCSM Yearly Current Assets VS Current LiabilitesNCSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

3. NCSM Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 218.01% over the past year.
  • Looking at the last year, NCSM shows a quite strong growth in Revenue. The Revenue has grown by 12.96% in the last year.
  • Measured over the past years, NCSM shows a quite strong growth in Revenue. The Revenue has been growing by 11.41% on average per year.
EPS 1Y (TTM)218.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%284.85%
Revenue 1Y (TTM)12.96%
Revenue growth 3Y5.68%
Revenue growth 5Y11.41%
Sales Q2Q%12.5%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • Based on estimates for the next years, NCSM will show a small growth in Revenue. The Revenue will grow by 6.00% on average per year.
EPS Next Y-47.46%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.2%
Revenue Next 2Y6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NCSM Yearly Revenue VS EstimatesNCSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
NCSM Yearly EPS VS EstimatesNCSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 -10 -15

6

4. NCSM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.44, which indicates a rather cheap valuation of NCSM.
  • 95.00% of the companies in the same industry are more expensive than NCSM, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 24.89. NCSM is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 14.16, the valuation of NCSM can be described as correct.
  • NCSM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NCSM is cheaper than 80.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. NCSM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 7.44
Fwd PE 14.16
NCSM Price Earnings VS Forward Price EarningsNCSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as NCSM.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NCSM indicates a rather cheap valuation: NCSM is cheaper than 93.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.54
EV/EBITDA 9.5
NCSM Per share dataNCSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. NCSM Dividend Analysis

5.1 Amount

  • No dividends for NCSM!.
Industry RankSector Rank
Dividend Yield 0%

NCSM Fundamentals: All Metrics, Ratios and Statistics

NCS MULTISTAGE HOLDINGS INC

NASDAQ:NCSM (3/30/2026, 12:24:37 PM)

61.74

-11.26 (-15.42%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)03-04
Earnings (Next)04-28
Inst Owners15.52%
Inst Owner Change0.02%
Ins Owners10.64%
Ins Owner Change9.11%
Market Cap157.44M
Revenue(TTM)183.63M
Net Income(TTM)23.75M
Analysts85.71
Price Target50.49 (-18.22%)
Short Float %0.14%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)326.59%
Min EPS beat(2)26.12%
Max EPS beat(2)627.07%
EPS beat(4)4
Avg EPS beat(4)227.56%
Min EPS beat(4)26.12%
Max EPS beat(4)627.07%
EPS beat(8)8
Avg EPS beat(8)640.29%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.61%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)10.13%
Revenue beat(4)3
Avg Revenue beat(4)11.94%
Min Revenue beat(4)-0.92%
Max Revenue beat(4)28.84%
Revenue beat(8)7
Avg Revenue beat(8)8.68%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)15.41%
EPS NQ rev (3m)15.41%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 7.44
Fwd PE 14.16
P/S 0.86
P/FCF 7.54
P/OCF 7.1
P/B 1.25
P/tB 1.52
EV/EBITDA 9.5
EPS(TTM)8.3
EY13.44%
EPS(NY)4.36
Fwd EY7.06%
FCF(TTM)8.18
FCFY13.25%
OCF(TTM)8.7
OCFY14.09%
SpS72.01
BVpS49.51
TBVpS40.73
PEG (NY)N/A
PEG (5Y)N/A
Graham Number96.15
Profitability
Industry RankSector Rank
ROA 13.11%
ROE 18.81%
ROCE 6.97%
ROIC 5.51%
ROICexc 7.25%
ROICexgc 8.98%
OM 5.79%
PM (TTM) 12.93%
GM 41.08%
FCFM 11.36%
ROA(3y)5.12%
ROA(5y)2.25%
ROE(3y)7.35%
ROE(5y)3.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y-0.07%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.37
Debt/EBITDA 0.32
Cap/Depr 22.21%
Cap/Sales 0.71%
Interest Coverage 141.87
Cash Conversion 134.19%
Profit Quality 87.87%
Current Ratio 4.27
Quick Ratio 2.91
Altman-Z 2.04
F-Score6
WACC8.74%
ROIC/WACC0.63
Cap/Depr(3y)31.88%
Cap/Depr(5y)28.05%
Cap/Sales(3y)1.03%
Cap/Sales(5y)0.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)218.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%284.85%
EPS Next Y-47.46%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.96%
Revenue growth 3Y5.68%
Revenue growth 5Y11.41%
Sales Q2Q%12.5%
Revenue Next Year7.2%
Revenue Next 2Y6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y145.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year266.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y83.92%
FCF growth 3YN/A
FCF growth 5Y-8.74%
OCF growth 1Y74.26%
OCF growth 3YN/A
OCF growth 5Y-8.79%

NCS MULTISTAGE HOLDINGS INC / NCSM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NCS MULTISTAGE HOLDINGS INC (NCSM) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NCSM.


Can you provide the valuation status for NCS MULTISTAGE HOLDINGS INC?

ChartMill assigns a valuation rating of 6 / 10 to NCS MULTISTAGE HOLDINGS INC (NCSM). This can be considered as Fairly Valued.


What is the profitability of NCSM stock?

NCS MULTISTAGE HOLDINGS INC (NCSM) has a profitability rating of 5 / 10.


What are the PE and PB ratios of NCS MULTISTAGE HOLDINGS INC (NCSM) stock?

The Price/Earnings (PE) ratio for NCS MULTISTAGE HOLDINGS INC (NCSM) is 7.44 and the Price/Book (PB) ratio is 1.25.


How financially healthy is NCS MULTISTAGE HOLDINGS INC?

The financial health rating of NCS MULTISTAGE HOLDINGS INC (NCSM) is 7 / 10.